AZ fills top R&D spot with Genentech's Bohen; Regulators OK Pfizer's Hospira deal;

> Genentech's Sean Bohen will take up the post as AstraZeneca's ($AZN) R&D chief. More

> Regulators have approved Pfizer's ($PFE) Hospira ($HSP) buyout deal, pending the divestiture of some sterile injectable drugs. Report

> Bayer HealthCare has launched a digital healthcare accelerator in Berlin. Report

> South Korean pharmaceutical companies are beefing up their presence in the global healthcare industry through global partnerships. More

> Merck KGaA will close down Bangalore GeNei, a company it acquired in 2009 to boost its capabilities in design, development and production of biological research products. More

And Finally... Google's ($GOOG) Life Sciences division is developing a wearable blood glucose monitor that could revolutionize diabetic care and treatment. Report

Suggested Articles

Breztri Aerosphere, AZ's three-in-one COPD inhaler, just won its first global nod to rival GlaxoSmithKline's Trelegy Ellipta.

Could an overhauled marketing campaign featuring new pain data help sales of Ironwood and Allergan’s struggling GI drug Linzess?

Forget the charts and graphs. Lead with your heart. That’s the message from Attila Cansun, a chief marketing officer at the newly rebranded P&G Health.